Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis

Journal of Gastroenterology

Volumn 44, Issue 1, 2009, Pages 71-75

  Matsushita, Mitsunobu ^a   Takakuwa, Hiroshi ^b   Shimeno, Naoto ^b   Uchida, Kazushige ^a   Nishio, Akiyoshi ^a   Okazaki, Kazuichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TENRI HOSPITAL   (Japan)

Author keywords

Endoscopic retrograde cholangiopancreatography; Epinephrine; Pancreatitis; Papillary edema

Indexed keywords

ADRENALIN; AMYLASE; SODIUM CHLORIDE; TRIACYLGLYCEROL LIPASE;

ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BILE DUCT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PANCREAS ACINUS; PANCREAS DUCT; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VATER PAPILLA;

ADMINISTRATION, TOPICAL; AGED; AMPULLA OF VATER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; EPINEPHRINE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; VASOCONSTRICTOR AGENTS;

EID: 59049105824     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2272-8     Document Type: Article

References (22)

1. 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy. Gut 1997;41:690-695.
2. Johnson GK, Geenen JE, Johanson JF, Shermal S, Hogan WJ, Cass O (Midwest Pancreaticobiliary Study Group). Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 1997;46:217-222.
3. Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman J, et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997;29:252-257.
4. Ohashi A, Tamada K, Tomiyama T, Wada S, Higashizawa T, Gotoh Y, et al. Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty. J Gastroenterol Hepatol 2001;16:568-571.
5. Schwartz JJ, Lew RJ, Ahmad NA, Shah JN, Ginsberg GG, Kochman ML, et al. The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc 2004;59:179-184.
6. Wehrmann T, Schmitt T, Stergiou N, Capary WF, Seifert H. Topical application of nitrates onto the papilla of Vater: Manometric and clinical results. Endoscopy 2001;33:323-328.
7. Ohno T, Katori M, Nishiyama K, Saigenji K. Direct observation of microcirculation of the basal region of rat gastric mucosa. J Gastroenterol 1995;30:557-564.
8. Igawa M, Miyaoka M, Saitoh T. Influence of topical epinephrine application on microcirculatory disturbance in subjects with ulcerative colitis evaluated by laser Doppler flowmetry and transmission electron microscopy. Dig Endosc 2000;12:126-130.
9. Panteghini M, Pagani F, Alebardi O, Lancini G, Cestari R. Time course of changes in pancreatic enzymes, isoenzymes, and isoforms in serum after endoscopic retrograde cholangiopancreatography. Clin Chem 1991;37:1602-1605.
10. Messmann H, Vogt W, Holstege A, Lock G, Heinisch A, von Furstenberg A, et al. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997;40:80-85.
11. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RCG, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991;37:383-393.
12. Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003;57:291-294.
13. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918.
14. Devie're J, Moine OL, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
15. Murray B, Carter R, Imrie C, Evans S, O'suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124:1786-1791.
16. Poon RTP, Yeung C, Liu CL, Lam CM, Yuen WK, Lo CM, et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: A randomized controlled trial. Gut 2003;52:1768-1773.
17. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Francesco VD. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996;335:919-923.
18. Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, et al. Ulinastatine for pancreatitis after endoecopic retrograde cholangiopancreatography: A randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:376-383.
19. Moreto' M, Zaballa M, Casado I, Merino O, Rueda M, Rami'rez K, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc 2003;57:1-7.
20. Rabenstein T, Roggenbuck S, Framke B, Martus P, Fischer B, Nusko G, et al. Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002;55:476-483.
21. Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamider P, et al. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc 2005;62:245-250.
22. Nowak A, Nowakowska-Dutawa E, Rybicka J. Patency of the Santorini duct and acute biliary pancreatitis. A prospective ERCP study. Endoscopy 1990;22:124-126.